| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |